Heart disease has been the leading cause of death in the U.S. for 100 years, according to the American Heart Association’s 2024 Heart Disease and Stroke Statistics report. For decades, beta-blockers ...

A class of drugs called beta-blockers — used for decades as a first-line treatment after a heart attack— doesn’t benefit the vast majority of patients and may contribute to a higher risk of ...

As a cardiologist, I frequently meet patients who have stopped taking medicines that could keep them alive. Often it’s because they’ve seen a dramatic headline or a worrying TV report about a drug ...

In a new research trial, beta-blockers didnt appear to offer meaningful benefit to heart attack survivors with preserved heart function. A sub-study within the same trial suggests that women ...

Beta blockers—drugs commonly prescribed for a range of cardiac conditions, including heart attacks—provide no clinical benefit for patients who have had an uncomplicated myocardial infarction with ...

A new study out of Europe has called into question the effectiveness of beta blockers, one of the most frequently prescribed ...

Beta blockers may provide no clinical benefit to patients who maintain normal heart function following a heart attack, according to a study published Aug. 30 in The New England Journal of Medicine.

Beta blockers—drugs commonly prescribed after a heart attack—may not actually help a large number of patients. This is the "breakthrough" claim of researchers who report that the medicines provide no ...

The evidence supporting beta-blocker therapy after myocardial infarction was established before the introduction of modern coronary reperfusion therapy and secondary prevention strategies. In an ...